Literature DB >> 11325798

Protection against beta-amyloid peptide toxicity in vivo with long-term administration of ferulic acid.

J J Yan1, J Y Cho, H S Kim, K L Kim, J S Jung, S O Huh, H W Suh, Y H Kim, D K Song.   

Abstract

1. beta-Amyloid peptide (A beta), a 39 -- 43 amino acid peptide, is believed to induce oxidative stress and inflammation in the brain, which are postulated to play important roles in the pathogenesis of Alzheimer's disease. Ferulic acid is an antioxidant and anti-inflammatory agent derived from plants; therefore, the potential protective activity of ferulic acid against A beta toxicity in vivo was examined. 2. Mice were allowed free access to drinking water (control) or water containing ferulic acid (0.006%). After 4 weeks, A beta 1-42 (410 pmol) was administered via intracerebroventricular injection. 3. Injection of control mice with A beta 1-42 impaired performance on the passive avoidance test (35% decrease in step-through latency), the Y-maze test (19% decrease in alternation behaviour), and the water maze test (32% decrease in percentage time in platform-quadrant). In contrast, mice treated with ferulic acid prior to A beta 1-42 administration were protected from these changes (9% decrease in step-through latency; no decrease in alternation behaviour; 14% decrease in percentage time in platform-quadrant). A beta 1-42 induced 31% decrease in acetylcholine level in the cortex, which was tended to be ameliorated by ferulic acid. 4. In addition, A beta 1-42 increased immunoreactivities of the astrocyte marker glial fibrillary acidic protein (GFAP) and interleukin-1 beta (IL-1 beta) in the hippocampus, effects also suppressed by pretreatment with ferulic acid. 5. Administration of ferulic acid per se unexpectedly induced a transient and slight increase in GFAP and IL-1 beta immunoreactivity in the hippocampus on day 14, which returned to basal levels on day 28. A slight (8%) decrease in alternation behaviour was observed on day 14. 6. These results demonstrate that long-term administration of ferulic acid induces resistance to A beta 1-42 toxicity in the brain, and suggest that ferulic acid may be a useful chemopreventive agent against Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11325798      PMCID: PMC1572763          DOI: 10.1038/sj.bjp.0704047

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  45 in total

1.  Memory impairment and neuronal dysfunction induced by beta-amyloid protein in rats.

Authors:  T Nabeshima; A Nitta
Journal:  Tohoku J Exp Med       Date:  1994-11       Impact factor: 1.848

2.  Interleukin-1 beta (IL-1 beta) and tumour necrosis factor (TNF) inhibit long-term potentiation in the rat dentate gyrus in vitro.

Authors:  A J Cunningham; C A Murray; L A O'Neill; M A Lynch; J J O'Connor
Journal:  Neurosci Lett       Date:  1996-01-12       Impact factor: 3.046

3.  Amyloid beta peptide potentiates cytokine secretion by interleukin-1 beta-activated human astrocytoma cells.

Authors:  B D Gitter; L M Cox; R E Rydel; P C May
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

4.  Inhibitory effect of ferulic acid and isoferulic acid on murine interleukin-8 production in response to influenza virus infections in vitro and in vivo.

Authors:  T Hirabayashi; H Ochiai; S Sakai; K Nakajima; K Terasawa
Journal:  Planta Med       Date:  1995-06       Impact factor: 3.352

5.  Amnesia induced in mice by centrally administered beta-amyloid peptides involves cholinergic dysfunction.

Authors:  T Maurice; B P Lockhart; A Privat
Journal:  Brain Res       Date:  1996-01-15       Impact factor: 3.252

6.  beta-Amyloid protein-induced Alzheimer's disease animal model.

Authors:  A Nitta; A Itoh; T Hasegawa; T Nabeshima
Journal:  Neurosci Lett       Date:  1994-03-28       Impact factor: 3.046

7.  Astroglial and microglial reactions in the gerbil hippocampus with induced ischemic tolerance.

Authors:  H Kato; K Kogure; T Araki; Y Itoyama
Journal:  Brain Res       Date:  1994-11-21       Impact factor: 3.252

8.  [Sodium ferulate alleviated paracetamol-induced liver toxicity in mice].

Authors:  H Wang; R X Peng
Journal:  Zhongguo Yao Li Xue Bao       Date:  1994-01

9.  Spreading depression induces tolerance of cortical neurons to ischemia in rat brain.

Authors:  S Kobayashi; V A Harris; F A Welsh
Journal:  J Cereb Blood Flow Metab       Date:  1995-09       Impact factor: 6.200

10.  Protective effect of spreading depression against neuronal damage following cardiac arrest cerebral ischaemia.

Authors:  N Kawahara; C A Ruetzler; I Klatzo
Journal:  Neurol Res       Date:  1995-02       Impact factor: 2.448

View more
  66 in total

1.  3,6'-Dithiothalidomide, a new TNF-α synthesis inhibitor, attenuates the effect of Aβ1-42 intracerebroventricular injection on hippocampal neurogenesis and memory deficit.

Authors:  Isabella Russo; Luca Caracciolo; David Tweedie; Sang-Ho Choi; Nigel H Greig; Sergio Barlati; Francesca Bosetti
Journal:  J Neurochem       Date:  2012-07-25       Impact factor: 5.372

2.  Ferulic Acid Improves Cognitive Skills Through the Activation of the Heme Oxygenase System in the Rat.

Authors:  Emanuela Mhillaj; Stefania Catino; Fiorella M Miceli; Rosaria Santangelo; Luigia Trabace; Vincenzo Cuomo; Cesare Mancuso
Journal:  Mol Neurobiol       Date:  2017-01-12       Impact factor: 5.590

Review 3.  A Review on Potential Footprints of Ferulic Acid for Treatment of Neurological Disorders.

Authors:  Surabhi Thapliyal; Tanveer Singh; Shailendra Handu; Manisha Bisht; Puja Kumari; Priyanka Arya; Pallavi Srivastava; Ravi Gandham
Journal:  Neurochem Res       Date:  2021-02-05       Impact factor: 3.996

4.  Treadmill Exercise Ameliorates Spatial Learning and Memory Deficits Through Improving the Clearance of Peripheral and Central Amyloid-Beta Levels.

Authors:  Davar Khodadadi; Reza Gharakhanlou; Naser Naghdi; Mona Salimi; Mohammad Azimi; Atabak Shahed; Soomaayeh Heysieattalab
Journal:  Neurochem Res       Date:  2018-06-11       Impact factor: 3.996

5.  Combination therapy with octyl gallate and ferulic acid improves cognition and neurodegeneration in a transgenic mouse model of Alzheimer's disease.

Authors:  Takashi Mori; Naoki Koyama; Jun Tan; Tatsuya Segawa; Masahiro Maeda; Terrence Town
Journal:  J Biol Chem       Date:  2017-05-16       Impact factor: 5.157

6.  Antidepressant-like effects of ferulic acid: involvement of serotonergic and norepinergic systems.

Authors:  Jianliang Chen; Dan Lin; Chong Zhang; Gaowen Li; Nianping Zhang; Lina Ruan; Qizhi Yan; Jianxin Li; Xuefeng Yu; Xupei Xie; Cong Pang; Liang Cao; Jianchun Pan; Ying Xu
Journal:  Metab Brain Dis       Date:  2014-12-09       Impact factor: 3.584

Review 7.  What can rodent models tell us about cognitive decline in Alzheimer's disease?

Authors:  Sabrina Davis; Serge Laroche
Journal:  Mol Neurobiol       Date:  2003-06       Impact factor: 5.590

8.  Ginsennoside rd attenuates cognitive dysfunction in a rat model of Alzheimer's disease.

Authors:  Juanfang Liu; Xiaodong Yan; Ling Li; Yi Zhu; Kefeng Qin; Linfu Zhou; Dong Sun; Xiaohui Zhang; Ruidong Ye; Gang Zhao
Journal:  Neurochem Res       Date:  2012-08-18       Impact factor: 3.996

9.  Cyclooxygenase-1 null mice show reduced neuroinflammation in response to beta-amyloid.

Authors:  Sang-Ho Choi; Francesca Bosetti
Journal:  Aging (Albany NY)       Date:  2009-02-11       Impact factor: 5.682

Review 10.  Hybrids: a new paradigm to treat Alzheimer's disease.

Authors:  Manjinder Singh; Maninder Kaur; Navriti Chadha; Om Silakari
Journal:  Mol Divers       Date:  2015-09-02       Impact factor: 2.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.